Senores Pharmaceuticals Limited
- SENORES
- BSE 544319
- Healthcare
- Pharmaceuticals
Rs 1,174.60−42.40 (−3.48%)
- As of 13 Nov 2026
- NSE end-of-day
Over one year the closing price rose 48.18% to Rs 1,174.60 (13 Nov 2026).
Rs 1,551Rs 710
From 14 Nov 2025 to 13 Nov 2026.14 Nov 202513 Nov 2026
Snapshot
Snapshot: The headline figures: market value, P/E, P/B, the 52-week range and the listing date, from the latest close and the latest filed results. The i beside each label says what it means.- As of 13 Nov 2026
- NSE, filings
- Rs 5,409 Cr
- 38.25x
- 5.39x
- 30 Dec 2024
- Rs 706.00 – 1,599.00
What changed
- 9 items in 120 days
Financials
- Sales Rs 722 Cr
- Net profit Rs 137 Cr
Ownership
- Promoters 45.82%
- FIIs 6.01% · DIIs 10.84%
Peers
- 16 companies
Filings
- 137 in 12 months
What changed
What changed: Filings and results from the report window, newest first, each linked to the original filing. Items after the first four need a free sign-in.- As of 15 Nov 2026
- BSE and NSE filings
9 items in the last 120 days. Latest on 5 Nov 2026: Management guided revenue growth to 30% to 40%, against 18.9% reported in Q2 FY27. Management guided EBITDA margin to 30% plus, against 34.63% reported in Q2 FY27. Management stated cost pressure: Initial setup and operating costs for Zoraya and Amerisyn, without corresponding revenue contribution. Management stated cost provision: INR4 crores of expenses pertaining to Zoraya and Amerisyn this quarter. Management stated revenue guidance: About 100-odd crores plus of revenue this year.
- 5 Nov 2026Guidance updateManagement guided revenue growth to 30% to 40%, against 18.9% reported in Q2 FY27. Management guided EBITDA margin to 30% plus, against 34.63% reported in Q2 FY27. Management stated cost pressure: Initial setup and operating costs for Zoraya and Amerisyn, without corresponding revenue contribution. Management stated cost provision: INR4 crores of expenses pertaining to Zoraya and Amerisyn this quarter. Management stated revenue guidance: About 100-odd crores plus of revenue this year.Filing
- 29 Oct 2026Financial resultsRevenue changed +58.9% from the prior financial year.No filing link
- 29 Oct 2026Guidance updateDisclosed to the exchange. Open the filing for the full text.Filing
- 26 Aug 2026AcquisitionDisclosed to the exchange. Open the filing for the full text.Filing
Showing 4 of 9 items on filings and results.
Sign in free to read the rest. A free account, with Google or email. You come back to this section.
About the company
About the company: Classification and registration facts from the exchanges, the reportable segments, and what the company does in its own words where its annual report gives it.- As of 13 Nov 2026
- NSE and BSE listings
Healthcare · Pharmaceuticals · listed 30 Dec 2024 · in BSE Healthcare.
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Listed
- 30 Dec 2024
- Face value
- Rs 10
- Indices
- BSE Healthcare
- ISIN
- INE0RB801010
- NSE symbol
- SENORES
- BSE code
- 544319
What the company does is not in our data yet.
A description from the company's own annual report, linked to the page it comes from, will appear here. We do not write one ourselves.
Financials
Financials: Quarterly results and annual statements from the company's filings, in Rs crore. The i beside a label says what it means.- Consolidated
- Rs Cr
- As of 30 Sept 2026
- BSE, NSE filings
Sales Rs 192.33 Cr in Q2 FY27 (QoQ +6.73%, YoY +18.90%) · net profit Rs 36.60 Cr.
8 of 20 quarters in our data. Listed 30 Dec 2024, so earlier quarters do not exist in exchange filings.
Quarterly sales went from Rs 103.02 Cr (Q3 FY25) to Rs 192.33 Cr (Q2 FY27) over the 8 quarters shown. Net profit went from Rs 16.43 Cr to Rs 36.60 Cr over the same 8 quarters. Against the previous quarter, sales rose 6.73% and net profit rose 20.20%. Against the same quarter last year, sales rose 18.90% and net profit rose 21.51%.
Scale starts at Rs 50 Cr, not zero, so the differences are easier to see.
QoQ
+10.9%+20.8%+17.2%+7.9%+0.4%+2.9%+6.7%
YoY
+69.5%+53.4%+30.6%+18.9%
QoQ
+9.4%+17.9%+42.2%+11.5%+9.2%−17.0%+20.2%
YoY
+104.4%+104.1%+43.8%+21.5%
Quarterly results
| Rs Cr, consolidated | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 |
|---|---|---|---|---|---|---|---|---|
| SalesSales: Revenue from operations in the period. Revenue from operations as filed for the quarter or year shown.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: revenue from operations. Unit: rupees. Period basis: the quarter or year shown. Applies to: General companies. Not banks, NBFCs or insurers. Source: Quarterly and annual filings. | 103.02 | 114.21 | 137.99 | 161.76 | 174.56 | 175.19 | 180.21 | 192.33 |
| change QoQQoQ: The change from the previous quarter to the latest quarter, as a percentage of the earlier figure. Latest quarter figure minus previous quarter figure, divided by the previous quarter figure, shown as a percent. Both quarters are on the same statement basis. Inputs: latest quarter figure, previous quarter figure. Unit: percent. Period basis: one quarter apart. No meaningful value when: The earlier figure is zero or a loss. A percent of zero cannot be worked out, and a percent of a loss has no clear meaning. Applies to: All companies. Source: The company's quarterly filings. | +10.86% | +20.82% | +17.23% | +7.91% | +0.36% | +2.87% | +6.73% | |
| change YoYYoY: The change from the same period a year earlier to the latest period, as a percentage of the earlier figure. Latest figure minus the figure for the same quarter a year earlier (or the previous year, for annual figures), divided by the earlier figure, shown as a percent. Inputs: latest figure, figure a year earlier. Unit: percent. Period basis: twelve months apart. No meaningful value when: The earlier figure is zero or a loss. A percent of zero cannot be worked out, and a percent of a loss has no clear meaning. Applies to: All companies. Source: The company's quarterly and annual filings. | +69.45% | +53.39% | +30.60% | +18.90% | ||||
| Net profitNet profit: What is left of the period's income after all costs, interest and tax. For consolidated figures it is the whole group's profit, including the share that belongs to non-controlling shareholders. Profit after tax as filed for the quarter or year shown. For consolidated figures it includes the share attributable to non-controlling interests; net profit attributable to owners is the owners' share. A negative figure is a loss.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: profit after tax. Unit: rupees. Period basis: the quarter or year shown. Applies to: All companies. Source: Quarterly and annual filings. | 16.43 | 17.97 | 21.18 | 30.12 | 33.58 | 36.67 | 30.45 | 36.60 |
| change QoQQoQ: The change from the previous quarter to the latest quarter, as a percentage of the earlier figure. Latest quarter figure minus previous quarter figure, divided by the previous quarter figure, shown as a percent. Both quarters are on the same statement basis. Inputs: latest quarter figure, previous quarter figure. Unit: percent. Period basis: one quarter apart. No meaningful value when: The earlier figure is zero or a loss. A percent of zero cannot be worked out, and a percent of a loss has no clear meaning. Applies to: All companies. Source: The company's quarterly filings. | +9.38% | +17.86% | +42.21% | +11.49% | +9.20% | −16.96% | +20.20% | |
| change YoYYoY: The change from the same period a year earlier to the latest period, as a percentage of the earlier figure. Latest figure minus the figure for the same quarter a year earlier (or the previous year, for annual figures), divided by the earlier figure, shown as a percent. Inputs: latest figure, figure a year earlier. Unit: percent. Period basis: twelve months apart. No meaningful value when: The earlier figure is zero or a loss. A percent of zero cannot be worked out, and a percent of a loss has no clear meaning. Applies to: All companies. Source: The company's quarterly and annual filings. | +104.39% | +104.06% | +43.77% | +21.51% | ||||
| Net marginNet margin: Net profit as a percentage of revenue. Net profit divided by revenue, both over the last twelve months, shown as a percent. get_financials returns it as a fraction: 0.0888 is 8.88%. Inputs: net profit, revenue. Unit: percent. Period basis: trailing twelve months. No meaningful value when: Revenue is zero. Applies to: All companies. Source: Quarterly and annual filings. | 15.95% | 15.73% | 15.35% | 18.62% | 19.24% | 20.93% | 16.90% | 19.03% |
| Operating marginOperating margin: Profit before interest and tax as a percentage of revenue. Profit before tax plus finance costs, divided by revenue, both over the last twelve months, shown as a percent. It keeps other income in. The entry 'Operating margin (excluding other income)' gives a version that leaves it out. Inputs: profit before tax, finance costs, revenue. Unit: percent. Period basis: trailing twelve months. Applies to: General companies. Not banks, NBFCs or insurers. Source: Quarterly and annual filings. | 25.86% | 22.75% | 22.85% | 28.95% | 28.60% | 31.89% | 25.88% | 29.30% |
| EPSEPS: Earnings per share: net profit divided by the number of shares. Profit after tax divided by the weighted average number of shares, in rupees per share, as filed for the period shown. Inputs: profit after tax, weighted average number of shares. Unit: rupees per share. Period basis: the quarter or year shown. Applies to: All companies. Source: Quarterly and annual filings. | 5.04 | 3.81 | 4.60 | 6.54 | 7.29 | 7.96 | 6.61 | 8.85 |
2 of 5 years in our data. Listed 30 Dec 2024, so earlier years do not exist in exchange filings.
Annual sales went from Rs 398.25 Cr (FY25) to Rs 632.63 Cr (FY26) over the 2 years shown. Net profit went from Rs 58.34 Cr to Rs 121.53 Cr over the same 2 years. Against the previous year, sales rose 58.85% and net profit rose 108.31%.
YoY
+58.9%
YoY
+108.3%
Annual results
| Annual, Rs Cr | FY25 | FY26 |
|---|---|---|
| SalesSales: Revenue from operations in the period. Revenue from operations as filed for the quarter or year shown.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: revenue from operations. Unit: rupees. Period basis: the quarter or year shown. Applies to: General companies. Not banks, NBFCs or insurers. Source: Quarterly and annual filings. | 398.25 | 632.63 |
| change YoYYoY: The change from the same period a year earlier to the latest period, as a percentage of the earlier figure. Latest figure minus the figure for the same quarter a year earlier (or the previous year, for annual figures), divided by the earlier figure, shown as a percent. Inputs: latest figure, figure a year earlier. Unit: percent. Period basis: twelve months apart. No meaningful value when: The earlier figure is zero or a loss. A percent of zero cannot be worked out, and a percent of a loss has no clear meaning. Applies to: All companies. Source: The company's quarterly and annual filings. | +58.85% | |
| Net profitNet profit: What is left of the period's income after all costs, interest and tax. For consolidated figures it is the whole group's profit, including the share that belongs to non-controlling shareholders. Profit after tax as filed for the quarter or year shown. For consolidated figures it includes the share attributable to non-controlling interests; net profit attributable to owners is the owners' share. A negative figure is a loss.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: profit after tax. Unit: rupees. Period basis: the quarter or year shown. Applies to: All companies. Source: Quarterly and annual filings. | 58.34 | 121.53 |
| change YoYYoY: The change from the same period a year earlier to the latest period, as a percentage of the earlier figure. Latest figure minus the figure for the same quarter a year earlier (or the previous year, for annual figures), divided by the earlier figure, shown as a percent. Inputs: latest figure, figure a year earlier. Unit: percent. Period basis: twelve months apart. No meaningful value when: The earlier figure is zero or a loss. A percent of zero cannot be worked out, and a percent of a loss has no clear meaning. Applies to: All companies. Source: The company's quarterly and annual filings. | +108.31% | |
| Net marginNet margin: Net profit as a percentage of revenue. Net profit divided by revenue, both over the last twelve months, shown as a percent. get_financials returns it as a fraction: 0.0888 is 8.88%. Inputs: net profit, revenue. Unit: percent. Period basis: trailing twelve months. No meaningful value when: Revenue is zero. Applies to: All companies. Source: Quarterly and annual filings. | 14.65% | 19.21% |
| Operating marginOperating margin: Profit before interest and tax as a percentage of revenue. Profit before tax plus finance costs, divided by revenue, both over the last twelve months, shown as a percent. It keeps other income in. The entry 'Operating margin (excluding other income)' gives a version that leaves it out. Inputs: profit before tax, finance costs, revenue. Unit: percent. Period basis: trailing twelve months. Applies to: General companies. Not banks, NBFCs or insurers. Source: Quarterly and annual filings. | 23.13% | 29.11% |
| EPSEPS: Earnings per share: net profit divided by the number of shares. Profit after tax divided by the weighted average number of shares, in rupees per share, as filed for the period shown. Inputs: profit after tax, weighted average number of shares. Unit: rupees per share. Period basis: the quarter or year shown. Applies to: All companies. Source: Quarterly and annual filings. | 16.12 | 26.39 |
Balance sheet and cash flow, annual
| Annual, Rs Cr | FY25 | FY26 |
|---|---|---|
| Total assetsTotal assets: Everything the company owns, as reported on its balance sheet. The balance-sheet total as filed at the period end shown.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: balance-sheet total. Unit: rupees. Period basis: the balance-sheet date. Applies to: All companies. Source: Annual filing. | 1,226.86 | 1,603.81 |
| EquityEquity: Shareholders' equity attributable to the owners of the parent company, excluding non-controlling interests. Equity attributable to owners of the parent as filed at the balance-sheet date, excluding non-controlling interests. A standalone filing has none and gives its total equity.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: equity attributable to owners of the parent. Unit: rupees. Period basis: the balance-sheet date. Applies to: All companies. Source: Annual filing. | 786.18 | 933.60 |
| Total debtTotal debt: Borrowings reported on the balance sheet. The figure excludes lease liabilities. Current plus non-current borrowings as filed at the balance-sheet date. Lease liabilities are excluded: exchange filings do not give them as a separate balance-sheet line.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: current borrowings, non-current borrowings. Unit: rupees. Period basis: the balance-sheet date. Applies to: General companies. Not banks, NBFCs or insurers. Source: Annual filing. | 304.76 | 327.09 |
| CashCash: Cash and cash equivalents on the balance sheet. Cash and cash equivalents as filed at the balance-sheet date.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: cash and cash equivalents. Unit: rupees. Period basis: the balance-sheet date. Applies to: All companies. Source: Annual filing. | 105.38 | 45.55 |
| Operating cash flowOperating cash flow: Cash the business generated from its operations in the year, as reported. Net cash from operating activities as filed in the cash flow statement for the financial year shown.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: net cash from operating activities. Unit: rupees. Period basis: the financial year shown. Applies to: General companies. Not banks, NBFCs or insurers. Source: Annual filing. | −45.92 | 62.05 |
| Free cash flowFree cash flow: Operating cash flow minus capital spending, as reported. Net cash from operating activities minus capital expenditure for the financial year shown.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: net cash from operating activities, capital expenditure. Unit: rupees. Period basis: the financial year shown. No meaningful value when: Either figure is not disclosed for the year. Applies to: General companies. Not banks, NBFCs or insurers. Source: Annual filing. | −203.44 | −178.08 |
Data note on margins
Our computed net margin differs from BSE's own published figure.
What the data note says
Our computed net margin (19.01%) diverges from BSE's own published figure (3.82%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.Ownership
Ownership: Who held the shares at each quarter end, from the exchange shareholding filings. Each bar adds to 100%.- As of 30 Sept 2026
- BSE shareholding filings
Promoters 45.82% · FIIs 6.01% · DIIs 10.84% · retail and other 37.33% at 30 Sept 2026.
9 of 20 quarters in our data. Listed 30 Dec 2024, so only these quarters exist.
- PromotersPromoters: The founding or controlling shareholders named in the company's filing. The promoter and promoter-group holding is the percentage of shares in issue they hold, taken from the latest shareholding pattern. Inputs: promoter and promoter-group shares, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.
- FIIsFIIs: Foreign institutional investors: overseas funds and institutions holding the shares. The percentage of shares in issue held by foreign portfolio investors, taken from the latest shareholding pattern. Inputs: shares held by foreign portfolio investors, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.
- DIIsDIIs: Domestic institutional investors: Indian mutual funds, insurers and similar institutions. The percentage of shares in issue held by mutual funds, insurers, banks and other domestic institutions, taken from the latest shareholding pattern. Inputs: shares held by domestic institutions, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.
- Retail and otherRetail and other: Shares held by holders who are not promoters, foreign institutions or domestic institutions. Public-category holding minus foreign portfolio investor holding minus domestic institution holding, as a percent of shares in issue. The page shows it only when the institutional split is published for the quarter. Inputs: public-category holding, foreign portfolio investor holding, domestic institution holding, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. No meaningful value when: The foreign and domestic institutional split is not yet published for the quarter. Applies to: All companies. Source: Exchange shareholding filing.
- PromotersPromoters: The founding or controlling shareholders named in the company's filing. The promoter and promoter-group holding is the percentage of shares in issue they hold, taken from the latest shareholding pattern. Inputs: promoter and promoter-group shares, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.45.82%
- FIIsFIIs: Foreign institutional investors: overseas funds and institutions holding the shares. The percentage of shares in issue held by foreign portfolio investors, taken from the latest shareholding pattern. Inputs: shares held by foreign portfolio investors, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.6.01%
- DIIsDIIs: Domestic institutional investors: Indian mutual funds, insurers and similar institutions. The percentage of shares in issue held by mutual funds, insurers, banks and other domestic institutions, taken from the latest shareholding pattern. Inputs: shares held by domestic institutions, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.10.84%
- Retail and otherRetail and other: Shares held by holders who are not promoters, foreign institutions or domestic institutions. Public-category holding minus foreign portfolio investor holding minus domestic institution holding, as a percent of shares in issue. The page shows it only when the institutional split is published for the quarter. Inputs: public-category holding, foreign portfolio investor holding, domestic institution holding, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. No meaningful value when: The foreign and domestic institutional split is not yet published for the quarter. Applies to: All companies. Source: Exchange shareholding filing.37.33%
- Promoter pledgePromoter pledge: The share of the promoters' holding that is pledged or otherwise encumbered. Promoter shares pledged or otherwise encumbered divided by the promoters' total shares, shown as a percent. The base is the promoters' own holding. The same shares as a percent of all shares is a separate figure, promoter pledge as a share of all shares. Inputs: promoter shares pledged or otherwise encumbered, promoters' total shares. Unit: percent of the promoters' holding. Period basis: the latest quarter end. No meaningful value when: The company has no promoter group. Applies to: All companies. Source: Exchange shareholding filing.2.81%
Change in holding
Change from 30 Sept 2025 to 30 Sept 2026, 5 quarters.
| % of shares | Now | A window ago | Change |
|---|---|---|---|
| PromotersPromoters: The founding or controlling shareholders named in the company's filing. The promoter and promoter-group holding is the percentage of shares in issue they hold, taken from the latest shareholding pattern. Inputs: promoter and promoter-group shares, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | 45.82% | 45.80% | +0.02 pp |
| FIIsFIIs: Foreign institutional investors: overseas funds and institutions holding the shares. The percentage of shares in issue held by foreign portfolio investors, taken from the latest shareholding pattern. Inputs: shares held by foreign portfolio investors, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | 6.01% | 4.28% | +1.73 pp |
| DIIsDIIs: Domestic institutional investors: Indian mutual funds, insurers and similar institutions. The percentage of shares in issue held by mutual funds, insurers, banks and other domestic institutions, taken from the latest shareholding pattern. Inputs: shares held by domestic institutions, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | 10.84% | 8.61% | +2.23 pp |
| Retail and otherRetail and other: Shares held by holders who are not promoters, foreign institutions or domestic institutions. Public-category holding minus foreign portfolio investor holding minus domestic institution holding, as a percent of shares in issue. The page shows it only when the institutional split is published for the quarter. Inputs: public-category holding, foreign portfolio investor holding, domestic institution holding, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. No meaningful value when: The foreign and domestic institutional split is not yet published for the quarter. Applies to: All companies. Source: Exchange shareholding filing. | 37.33% | 41.31% | −3.98 pp |
| Promoter pledgePromoter pledge: The share of the promoters' holding that is pledged or otherwise encumbered. Promoter shares pledged or otherwise encumbered divided by the promoters' total shares, shown as a percent. The base is the promoters' own holding. The same shares as a percent of all shares is a separate figure, promoter pledge as a share of all shares. Inputs: promoter shares pledged or otherwise encumbered, promoters' total shares. Unit: percent of the promoters' holding. Period basis: the latest quarter end. No meaningful value when: The company has no promoter group. Applies to: All companies. Source: Exchange shareholding filing. | 2.81% | 0.00% | +2.81 pp |
FII holding rose from 4.28% (30 Sept 2025) to 6.01% (30 Sept 2026), up 1.73 percentage points over 5 quarters. DII holding rose from 8.61% (30 Sept 2025) to 10.84% (30 Sept 2026), up 2.23 percentage points over 5 quarters. Retail and other holding fell from 41.31% (30 Sept 2025) to 37.33% (30 Sept 2026), down 3.98 percentage points over 5 quarters. Promoter pledge rose from 0.00% (30 Sept 2025) to 2.81% (30 Sept 2026), up 2.81 percentage points over 5 quarters.
| % of shares | Now | A window ago | Change |
|---|---|---|---|
| PromotersPromoters: The founding or controlling shareholders named in the company's filing. The promoter and promoter-group holding is the percentage of shares in issue they hold, taken from the latest shareholding pattern. Inputs: promoter and promoter-group shares, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | |||
| FIIsFIIs: Foreign institutional investors: overseas funds and institutions holding the shares. The percentage of shares in issue held by foreign portfolio investors, taken from the latest shareholding pattern. Inputs: shares held by foreign portfolio investors, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | |||
| DIIsDIIs: Domestic institutional investors: Indian mutual funds, insurers and similar institutions. The percentage of shares in issue held by mutual funds, insurers, banks and other domestic institutions, taken from the latest shareholding pattern. Inputs: shares held by domestic institutions, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | |||
| Retail and otherRetail and other: Shares held by holders who are not promoters, foreign institutions or domestic institutions. Public-category holding minus foreign portfolio investor holding minus domestic institution holding, as a percent of shares in issue. The page shows it only when the institutional split is published for the quarter. Inputs: public-category holding, foreign portfolio investor holding, domestic institution holding, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. No meaningful value when: The foreign and domestic institutional split is not yet published for the quarter. Applies to: All companies. Source: Exchange shareholding filing. | |||
| Promoter pledgePromoter pledge: The share of the promoters' holding that is pledged or otherwise encumbered. Promoter shares pledged or otherwise encumbered divided by the promoters' total shares, shown as a percent. The base is the promoters' own holding. The same shares as a percent of all shares is a separate figure, promoter pledge as a share of all shares. Inputs: promoter shares pledged or otherwise encumbered, promoters' total shares. Unit: percent of the promoters' holding. Period basis: the latest quarter end. No meaningful value when: The company has no promoter group. Applies to: All companies. Source: Exchange shareholding filing. |
Change from 30 Sept 2024 to 30 Sept 2026, 9 quarters.
| % of shares | Now | A window ago | Change |
|---|---|---|---|
| PromotersPromoters: The founding or controlling shareholders named in the company's filing. The promoter and promoter-group holding is the percentage of shares in issue they hold, taken from the latest shareholding pattern. Inputs: promoter and promoter-group shares, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | 45.82% | 45.76% | +0.06 pp |
| FIIsFIIs: Foreign institutional investors: overseas funds and institutions holding the shares. The percentage of shares in issue held by foreign portfolio investors, taken from the latest shareholding pattern. Inputs: shares held by foreign portfolio investors, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | 6.01% | 5.51% | +0.50 pp |
| DIIsDIIs: Domestic institutional investors: Indian mutual funds, insurers and similar institutions. The percentage of shares in issue held by mutual funds, insurers, banks and other domestic institutions, taken from the latest shareholding pattern. Inputs: shares held by domestic institutions, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | 10.84% | 18.61% | −7.77 pp |
| Retail and otherRetail and other: Shares held by holders who are not promoters, foreign institutions or domestic institutions. Public-category holding minus foreign portfolio investor holding minus domestic institution holding, as a percent of shares in issue. The page shows it only when the institutional split is published for the quarter. Inputs: public-category holding, foreign portfolio investor holding, domestic institution holding, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. No meaningful value when: The foreign and domestic institutional split is not yet published for the quarter. Applies to: All companies. Source: Exchange shareholding filing. | 37.33% | 30.12% | +7.21 pp |
| Promoter pledgePromoter pledge: The share of the promoters' holding that is pledged or otherwise encumbered. Promoter shares pledged or otherwise encumbered divided by the promoters' total shares, shown as a percent. The base is the promoters' own holding. The same shares as a percent of all shares is a separate figure, promoter pledge as a share of all shares. Inputs: promoter shares pledged or otherwise encumbered, promoters' total shares. Unit: percent of the promoters' holding. Period basis: the latest quarter end. No meaningful value when: The company has no promoter group. Applies to: All companies. Source: Exchange shareholding filing. | 2.81% | 0.00% | +2.81 pp |
DII holding fell from 18.61% (30 Sept 2024) to 10.84% (30 Sept 2026), down 7.77 percentage points over 9 quarters. Retail and other holding rose from 30.12% (30 Sept 2024) to 37.33% (30 Sept 2026), up 7.21 percentage points over 9 quarters. Promoter pledge rose from 0.00% (30 Sept 2024) to 2.81% (30 Sept 2026), up 2.81 percentage points over 9 quarters.
All figures, every quarter
| % of shares | Sept 24 | Dec 24 | Mar 25 | Jun 25 | Sept 25 | Dec 25 | Mar 26 | Jun 26 | Sept 26 | Change |
|---|---|---|---|---|---|---|---|---|---|---|
| PromotersPromoters: The founding or controlling shareholders named in the company's filing. The promoter and promoter-group holding is the percentage of shares in issue they hold, taken from the latest shareholding pattern. Inputs: promoter and promoter-group shares, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | 45.76% | 45.76% | 45.77% | 45.78% | 45.80% | 45.80% | 45.82% | 45.82% | 45.82% | +0.06 pp |
| FIIsFIIs: Foreign institutional investors: overseas funds and institutions holding the shares. The percentage of shares in issue held by foreign portfolio investors, taken from the latest shareholding pattern. Inputs: shares held by foreign portfolio investors, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | 5.51% | 4.25% | 4.17% | 3.67% | 4.28% | 3.35% | 3.64% | 6.62% | 6.01% | +0.50 pp |
| DIIsDIIs: Domestic institutional investors: Indian mutual funds, insurers and similar institutions. The percentage of shares in issue held by mutual funds, insurers, banks and other domestic institutions, taken from the latest shareholding pattern. Inputs: shares held by domestic institutions, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing. | 18.61% | 11.78% | 9.65% | 9.51% | 8.61% | 9.31% | 9.61% | 9.77% | 10.84% | −7.77 pp |
| Retail and otherRetail and other: Shares held by holders who are not promoters, foreign institutions or domestic institutions. Public-category holding minus foreign portfolio investor holding minus domestic institution holding, as a percent of shares in issue. The page shows it only when the institutional split is published for the quarter. Inputs: public-category holding, foreign portfolio investor holding, domestic institution holding, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. No meaningful value when: The foreign and domestic institutional split is not yet published for the quarter. Applies to: All companies. Source: Exchange shareholding filing. | 30.12% | 38.21% | 40.41% | 41.04% | 41.31% | 41.54% | 40.93% | 37.79% | 37.33% | +7.21 pp |
| Promoter pledgePromoter pledge: The share of the promoters' holding that is pledged or otherwise encumbered. Promoter shares pledged or otherwise encumbered divided by the promoters' total shares, shown as a percent. The base is the promoters' own holding. The same shares as a percent of all shares is a separate figure, promoter pledge as a share of all shares. Inputs: promoter shares pledged or otherwise encumbered, promoters' total shares. Unit: percent of the promoters' holding. Period basis: the latest quarter end. No meaningful value when: The company has no promoter group. Applies to: All companies. Source: Exchange shareholding filing. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.90% | 1.90% | 2.81% | 2.81% | +2.81 pp |
Change from 30 Sept 2024 to 30 Sept 2026, 9 quarters.
Dividends and corporate actions
Dividends and corporate actions: Dividends, bonus issues and splits declared in the last five years, from the exchange's corporate-actions filings. Dividend per share is in rupees, by ex-date. A bonus or split changes the share count, so per-share amounts before and after it are not directly comparable.- BSE corporate actions
None since listing on 30 Dec 2024. No dividends, bonus issues, splits or demergers are on file; our window is the last five years.
Management and board
Management and board: Who sits on the board and who runs the company, as the company's annual report lists them, and the changes it has filed with the exchanges.- As of 29 Oct 2026
- BSE filings
8 filings under the exchange's board, directorate and management categories in the last twelve months · latest 29 Oct 2026.
Who sits on the board and who runs the company is not in our data yet.
Names, roles, independence, tenure and background, each linked to the annual report page it comes from, will appear here. Until then this section lists the changes the company has filed.
Changes filed with the exchanges
- 29 Oct 2026Management and directorsSenores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the CompanyFiling
- 13 Oct 2026Management and directorsThe Board at its meeting held today has re-appointed Mr. Swapnil Jatinbhai Shah as the Managing Director of the Company and Mr. Chetan Bipinchandra Shah as the Whole-time Director of the Company.Filing
- 13 Oct 2026Management and directorsThe Board of Directors of the Company at their Meeting held today i.e., Tuesday, October 13, 2026, has approved the following: 1. Re-Appointment of Mr. Swapnil Jatinbhai Shah (DIN: 05259821) ....Filing
- 26 Aug 2026Management and directorsSenores Pharmaceuticals Limited has informed the Exchange regarding Appointment of Independent DirectorFiling
- 26 Aug 2026Management and directorsSenores Pharmaceuticals Limited has informed the Exchange regarding appointment of Company Secretary and Compliance Officer of the CompanyFiling
- 27 Jul 2026Management and directorsSenores Pharmaceuticals Limited has informed the exchange regarding Appointment of Ms Anjali Shah as Assistant Vice President - Finance categorized as SMP of the Company w.e.f July 27, 2026Filing
Showing the latest 6 of 8. Every filing is listed under Filings and documents.
Peers
Peers: Companies in the same official BSE industry within a 0.1x to 10x market-cap band, chosen by a fixed rule from the exchange classification. It is a comparison set, not a ranking.- As of 13 Nov 2026
- NSE data and filings
16 companies in the same official industry · market cap Rs 5,409 Cr against a peer median of Rs 32,955 Cr. A comparison set, not a ranking.
| Company | CMP RsCurrent price: The latest end-of-day closing price of one share. The last closing price recorded by the exchange, in rupees per share. It updates once a day after the close. Inputs: closing price. Unit: rupees per share. Period basis: the latest trading day. Applies to: All companies. Source: Daily NSE prices. | Market cap Rs CrMarket cap: The market value of all the company's shares: share price times the number of shares in issue. Latest closing share price multiplied by the number of shares in issue, in rupees. Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: closing share price, number of shares in issue. Unit: rupees. Period basis: the latest close. Applies to: All companies. Source: Latest close and shares in issue. | Sales TTM Rs CrSales (trailing twelve months): Revenue over the last four reported quarters added together. The sum of revenue for the last four discrete quarters, in rupees. Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: quarterly revenue. Unit: rupees. Period basis: trailing twelve months. No meaningful value when: Fewer than four reported quarters are available. Applies to: All companies. | Profit TTM Rs CrNet profit (trailing twelve months): Profit after tax over the last four reported quarters added together. The sum of profit after tax for the last four discrete quarters, in rupees. Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: quarterly profit after tax. Unit: rupees. Period basis: trailing twelve months. No meaningful value when: Fewer than four reported quarters are available. Applies to: All companies. | P/E xP/E: Share price divided by earnings per share: how many rupees the market price is for each rupee of the company's yearly earnings. Latest closing share price divided by earnings per share over the last twelve months, as a number of times. Inputs: closing share price, earnings per share. Unit: times. Period basis: trailing twelve months. No meaningful value when: Earnings per share over the last twelve months are zero or a loss, or fewer than four quarters are reported. Applies to: All companies. Source: Latest close and trailing-twelve-month earnings per share. | ROE %ROE: Return on equity: profit the company earned for its owners as a percentage of the equity they have in it. Net profit attributable to owners over the last twelve months divided by average shareholders' equity, shown as a percent. Inputs: net profit attributable to owners, average shareholders' equity. Unit: percent. Period basis: trailing twelve months. No meaningful value when: Shareholders' equity is zero or a deficit, or the balance sheets needed for the average are not filed. Applies to: All companies. Source: Quarterly and annual filings. |
|---|---|---|---|---|---|---|
| IPCA Laboratories Limited | 1,884 | 47,797 | 10,479 | 1,484 | 34.08x | 18.68% |
| GlaxoSmithKline Pharmaceuticals Limited | 2,672.6 | 45,277 | 4,159 | 1,146.5 | 40.03x | 54.35% |
| Emcure Pharmaceuticals Limited | 2,361.7 | 44,804 | 10,234 | 1,092.7 | 40.96x | 23.28% |
| Ajanta Pharma Limited | 3,284 | 41,165 | 6,217 | 1,262.8 | 32.49x | 30.37% |
| Sai Life Sciences Limited | 1,928.8 | 40,972 | 2,371 | 376.2 | 16.31% | |
| JB Chemicals & Pharmaceuticals Limited | 2,408.9 | 38,687 | 4,148 | 709.5 | 53.22x | 18.80% |
| Acutaas Chemicals Limited | 4,039.1 | 33,069 | 1,593 | 438.6 | 75.30x | 29.64% |
| Wockhardt Limited | 2,027.2 | 32,841 | 3,751 | 405 | 80.32x | 8.82% |
| Piramal Pharma Limited | 244.54 | 32,484 | 9,779 | −209.4 | −2.56% | |
| Rubicon Research Limited | 1,677.2 | 27,763 | 2,100 | 324.8 | 85.05x | 22.94% |
| Neuland Laboratories Limited | 21,078 | 27,192 | 2,307 | 452.5 | 59.76x | 26.63% |
| Granules India Limited | 813.2 | 22,182 | 5,895 | 713.6 | 28.14x | 16.22% |
| Alembic Pharmaceuticals Limited | 1,030.15 | 20,248 | 8,477 | 839.8 | 24.00x | 15.46% |
| Shilpa Medicare Limited | 991.5 | 19,394 | 1,842 | 332.4 | 58.05x | 13.40% |
| Onesource Specialty Pharma Limited | 1,610.1 | 18,458 | 1,684 | −1.6 | −0.03% | |
| Senores Pharmaceuticals Limited | 1,174.6 | 5,409 | 722 | 137.3 | 38.25x | 11.85% |
| Median | 1,978 | 32,955 | 3,949 | 581 | 40.96x | 18.74% |
Filings and documents
Filings and documents: Every exchange filing in the last twelve months, ten to a page, with a filter by type. Each links to the original document.- As of 5 Nov 2026
- BSE filings
137 filings in twelve months · latest 5 Nov 2026 · most often investor communication (46). Types are grouped from the exchange's own sub-categories.
- 5 Nov 2026Investor communicationSenores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026The company's own statementFiling
- 30 Oct 2026Investor communicationSenores Pharmaceuticals Limited has informed the exchange regarding Newspaper publication extracts of unaudited financial results for the quarter and half year ended September 30, 2026Filing
- 29 Oct 2026Investor communicationSenores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026The company's own statementFiling
- 29 Oct 2026Deals, financing and ratingsSenores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible ....Filing
- 29 Oct 2026Results and reportsSenores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended on September 30, 2026Filing
- 29 Oct 2026Deals, financing and ratingsSenores Pharmaceuticals Limited has informed the exchange regarding Monitoring Agency report for the quarter ended September 30, 2026Filing
- 29 Oct 2026Results and reportsWe enclose herewith the Investor Presentation for Q2 & H1FY27Filing
- 29 Oct 2026Management and directorsSenores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the CompanyFiling
- 29 Oct 2026Investor communicationSenores Pharmaceuticals Limited has informed the exchange regarding media releaseFiling
- 29 Oct 2026Deals, financing and ratingsSenores Pharmaceuticals Limited has informed the exchange about subsidiary companies capacity expansionFiling
Showing 1–10 of 137Page 1 of 14
Sources and coverage
Sources and coverage: Where each figure comes from, and what this page could not cover, in words.- As of 15 Nov 2026
- DalalOS report
8 filings behind the report · coverage ready.
Sources
- Earnings Call Transcript · 05 Nov 2026
- Investor Presentation · 29 Oct 2026
- Acquisition · 26 Aug 2026
- Acquisition · 26 Aug 2026
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 · 12 Aug 2026
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 · 12 Aug 2026
- Earnings Call Transcript · 03 Aug 2026
- Investor Presentation · 27 Jul 2026
Not covered
No company-reported operating metrics are available.
This company has limited filing coverage. Sign in free to ask us to cover it in more depth.
Sign in freeSame official industry (Pharmaceuticals)
- IPCA Laboratories LimitedRs 47,797 Cr
- GlaxoSmithKline Pharmaceuticals LimitedRs 45,277 Cr
- Emcure Pharmaceuticals LimitedRs 44,804 Cr
- Ajanta Pharma LimitedRs 41,165 Cr
- Sai Life Sciences LimitedRs 40,972 Cr
- JB Chemicals & Pharmaceuticals LimitedRs 38,687 Cr
- Acutaas Chemicals LimitedRs 33,069 Cr
- Wockhardt LimitedRs 32,841 Cr
Other Healthcare companies of a similar market capitalisation
Companies are grouped mechanically from the exchange classification and listed by market capitalisation. This is a comparison set, not a ranking or recommendation.
Every value on this page was reported by the company or mechanically calculated from reported values. DalalOS does not estimate missing values or offer a view on whether to trade the security. Research and analysis only, not investment advice. DalalOS is not a SEBI-registered investment adviser.